Abattis Bioceuticals Announces $600,000 Private Placement and Added to the Official Marijuana Index(TM) - Video News Alert Summary on InvestmentPitch.com

Vancouver, British Columbia--(Newsfile Corp. - January 21, 2014) - Abattis Bioceuticals (CSE: FLU) (OTCPink: ATTBF) has been added to the official Marijuana Index™. For those of you rushing to locate The Marijuana Index™, it is at www.mmj-index.com.

InvestmentPitch.com has produced a "video news alert" discussing Abattis Bioceuticals. If this link is not enabled, please visit www.InvestmentPitch.com and enter "Abattis" in the search box.

If you cannot view the video above, please visit:
http://www.investmentpitch.com/video/0_wenu1osv/Abattis-Bioceuticals-CSE-FLU-has-been-added-to-the-official-Marijuana-Index

The Marijuana Index™, consisting of more than 25 companies, is the first and only registered equity tracking index which monitors the performance, new and general pulse of qualified marijuana or cannabis stocks. Weighted by market-cap, the index provides investors with a centralized view of these pioneering securities which are positioned in a multi-billion dollar growth industry.

Abattis is a specialty biotechnology company, which has the capabilities, through its wholly owned subsidiaries, to cultivate, license and market proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America.

Company management believes Abattis is positioned to capitalize on the fast growing trend toward marijuana legalization in the United States and for medicinal use in Canada and international jurisdictions.

The company can supply and partner with other companies to employ its vertical cultivation systems, extraction equipment and technology, and strategic marketing support to licensed growers.

Mike Withrow, President & CEO stated, "We have come one step closer to achieving another key milestone in the company's plan to become federally licensed under the MMPR. This will crystallise our efforts to complete our international strategy and be instrumental in delivering safe efficacious medicines and products that work."

The company has also announced a non-brokered private placement of up to $600,000 consisting of $0.05 units.

For more information, please visit the company's website www.abattis.com or contact Mike Withrow at 778-896-6536 or by email at mike.withrow@abattis.com.

About InvestmentPitch

InvestmentPitch.com, a multimedia company that provides a combined solution for creating and hosting financial video content, and distributing it across multiple platforms to investors and financial professionals, specializes in producing short three minute videos based on significant news releases, research reports and other market information. Please visit InvestmentPitch.com and browse the extensive library of investment videos.

CONTACT:
InvestmentPitch.com
Barry Morgan, CFO
604-684-5524
bmorgan@investmentpitch.com

Copyright 2014 Newsfile Corp. All rights reserved.
Terms and Conditions of Use | Privacy Policy | Anti-Spam Policy | Contact Us